TERT and breast cancer: We selected six genes (FGFR3, PIK3CA, RAS family genes, and TERT promoter) and determined their mutation profile in urine samples of BC patients, first at diagnosis, prior to treatment, and secondly, for NMIBC patients, during their follow-up.